IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats

BACKGROUND: Intestinal barrier dysfunction is not only the consequence of liver cirrhosis, but also an active participant in the development of liver cirrhosis. Previous studies showed that external administration of insulin-like growth factor 1 (IGF-1) improved intestinal barrier function in liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tian-Yu, Su, Li-Ping, Ma, Chun-Ye, Zhai, Xiao-Han, Duan, Zhi-Jun, Zhu, Ying, Zhao, Gang, Li, Chun-Yan, Wang, Li-Xia, Yang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495682/
https://www.ncbi.nlm.nih.gov/pubmed/26152281
http://dx.doi.org/10.1186/s12876-015-0311-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495682/
https://www.ncbi.nlm.nih.gov/pubmed/26152281
http://dx.doi.org/10.1186/s12876-015-0311-5

Ejemplares similares